Together Stronger: A Family-centered Lifestyle Intervention for Black Prostate Cancer Survivors and Their Caregivers

NCT ID: NCT07164456

Last Updated: 2025-09-10

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Clinical Phase

NA

Total Enrollment

648 participants

Study Classification

INTERVENTIONAL

Study Start Date

2026-02-14

Study Completion Date

2033-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

To establish the efficacy of the family-centered intervention in improving healthy lifestyle behaviors (MVPA and overall diet quality), as well as physical functioning, QoL, and family health climate, compared to survivor-only and control groups.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Primary Objectives

• Determine the extent to which MVPA and overall diet quality have improved in Black PCa survivors and their caregivers in the family-centered intervention group, compared to those in the survivor-only and control groups at post-intervention.

Secondary Objectives

* Determine the extent to which, compared to those in the survivor-only and control groups, both survivors and caregivers in the family-centered group maintain the MVPA and high diet quality at the 6-month follow-up, and experience improved 6MWT, QoL, and family health climate at both post-intervention and 6-month follow-up.
* Identify mediators and moderators of the family-centered intervention.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Family Centered Black Ethnicity Prostate Cancer Survivors

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

SINGLE_GROUP

Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Family-centered intervention

Includes a nutrition education session, a PA education session, and 12 health-coaching calls, all conducted via Zoom or phone.

Group Type EXPERIMENTAL

Education sessions

Intervention Type OTHER

Remote and In person sessions

Questionnaire

Intervention Type OTHER

Questionnaires given a 3,6,12 mouth follow ups

survivor-only intervention

Includes a nutrition education session, a PA education session, and 12 health-coaching calls, all conducted via Zoom or phone.

Group Type EXPERIMENTAL

Education sessions

Intervention Type OTHER

Remote and In person sessions

Questionnaire

Intervention Type OTHER

Questionnaires given a 3,6,12 mouth follow ups

Health education control

Will focus on enhancing participants' intrinsic motivation and problem-solving skills related to improving diet quality and engaging in PA. A total of 12 sessions will be provided, with approximately 2 sessions per month

Group Type EXPERIMENTAL

Education sessions

Intervention Type OTHER

Remote and In person sessions

Questionnaire

Intervention Type OTHER

Questionnaires given a 3,6,12 mouth follow ups

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Education sessions

Remote and In person sessions

Intervention Type OTHER

Questionnaire

Questionnaires given a 3,6,12 mouth follow ups

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Are adults (≥18 years old)
* Self-identify as Black or African American;
* Were diagnosed with stage 0-III PCa; completed PCa treatment; (5) are able to be physically active, as determined by responses to the Physical Activity Readiness Questionnaire (PAR-Q); and
* Have a family caregiver willing to participate together. Individuals under active surveillance for PCa will be included.

Caregivers are eligible if they:

* Are adults (≥18 years old)
* Are able to be physically active, as determined by responses to the

Exclusion Criteria

Survivors are excluded if they:

* Have a prior history of other cancer or have metastatic cancer.
* Have planned concomitant immunotherapy, hormonal therapy, chemotherapy, or radiation therapy during the study period.
* Meet physical activity recommendations (i.e., 150 min of moderate intensity physical activity per week); and (4) are currently participating in a lifestyle or weight management program.

Caregivers are excluded if they:

* Have serious medical conditions (e.g., cancer, congestive heart failure, stroke, and dementia)
* Are currently participating in a lifestyle or weight management program.
Minimum Eligible Age

18 Years

Eligible Sex

MALE

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

M.D. Anderson Cancer Center

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Dalnim Cho, MD

Role: PRINCIPAL_INVESTIGATOR

MD Andersson Cancer Center

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

MD Anderson Cancer Center

Houston, Texas, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Dalnim Cho, MD

Role: CONTACT

713-745-8476

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Dalnim Cho, MD

Role: primary

713-745-8476

Related Links

Access external resources that provide additional context or updates about the study.

http://www.mdanderson.org

MD Anderson Cancer Center

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

NCI-2025-06570

Identifier Type: OTHER

Identifier Source: secondary_id

2025-0868

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Prostate Conformal Cryotherapy
NCT00877682 COMPLETED NA